Fonte: Program. Nome do evento: Brazilian Congress of Pharmacology and Experimental Therapeutics. Unidade: FCFRP
Assuntos: ANTIPIRÉTICOS (EFEITOS), SISTEMA NERVOSO CENTRAL
ABNT
MALVAR, D. C. et al. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). 2012, Anais.. Foz do Iguaçu: SBFTE, 2012. . Acesso em: 16 ago. 2024.APA
Malvar, D. C., Aguiar, F. A., Vaz, A., Assis, D. C. R., Melo, M. C. C., Clososki, G. C., et al. (2012). Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). In Program. Foz do Iguaçu: SBFTE.NLM
Malvar DC, Aguiar FA, Vaz A, Assis DCR, Melo MCC, Clososki GC, Jabor VAP, Souza GEP de. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). Program. 2012 ;[citado 2024 ago. 16 ]Vancouver
Malvar DC, Aguiar FA, Vaz A, Assis DCR, Melo MCC, Clososki GC, Jabor VAP, Souza GEP de. Antipyretic effect and central nervous system amount of dipyrone active metabolites, 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA). Program. 2012 ;[citado 2024 ago. 16 ]